Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

CUSIP: 87978U108

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+3,949,140
Put/Call ratio
429%
SEC-reported price per share
$0.83
Number of holders
34
Value change
+$2,859,460
Number of buys
18
Open additional details 1 more signal available
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,815,636

Security key

87978U108

Report period

Q4 2024

Institutions

34

Top holders

10

Ownership snapshot

Top reported holders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Versant Vantage II, L.P.
Disclosed value leader
Versant Vantage II, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $10,127,118 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Versant Vantage II, L.P. has the largest disclosed position value at $10.13M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Versant Vantage II, L.P.'s linked filing trail.
Disclosed position value Top 5
Versant Vantage II, L.P. $10.13M
Versant Venture Capital VI, L.P. $2.56M
Rock Springs Capital Management LP $352.1K
BlackRock, Inc. $772.2K
Altium Capital Management LLC $763K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Versant Vantage II, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$10,127,118
2,118,644 shares
— 29 Apr 2022
Versant Venture Capital VI, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$2,562,608
2,328,585 shares
— 08 Aug 2024
Rock Springs Capital Management LP
3/4/5
10%+ Owner
—
denominator unverified
$352,066
73,654 shares
— 30 Dec 2021
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$772,222
551,587 shares
— 30 Sep 2024
Altium Capital Management LLC
13F
Company
13F
—
denominator unverified
$763,000
545,000 shares
— 30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$308,120
220,067 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
34
Shares
6,781,654
Rows available
34
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q4 2024 holders
34
Holder diff
33
Investor Q1 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q1 2026 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .